Eli Lilly Suspends COVID-19 Antibody Therapy Trial Over “Potential Safety Concern”

The pause in enrollment comes after Johnson & Johnson confirmed that it had voluntarily paused its Phase 3 vaccine trials after a participant in the 60k person trial came down with an unusual and unspecified illness. An AstraZeneca trial in the US has still not restarted more than a month after issues with a couple of patients caused them to briefly pause all trials around the world, though all the others have restarted.

Naturalblaze Eli Lilly Suspends COVID-19 Antibody Therapy Trial Over “Potential Safety Concern”